Maturitas
Volume 57, Issue 1 , Pages 27-30 , 20 May 2007

Androgens and the brain

References 

  1. Zumoff B, Walter L, Rosenfeld RS, et al. Sex differences in the 24-hour mean plasma concentrations od dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adult. J Clin Endocrinol Metab. 1980;51:331–334
  2. Longscope C, Franz C, Morello C, Baker K, Johnston CC. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas. 1986;8:189–196
  3. Rannevik G, Jeppsson S, Johnell O. A longitudinal study of the perimenopausal transition. Altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas. 1995;21:103
  4. Burger HG, Dudley EC, Hopper DL. The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin endocrinol Metab. 1995;80:3537–3545
  5. Simon JA. Estrogen replacement therapy: effects on the endogenous androgen milieu. Fertil Steril. 2002;77(Suppl. 4):S77–S82
  6. Liu CH, Laughlin GA, Fischer UG, Yen SSC. Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20 desmolase enzymatic activity. J Clin Endocrinol Metab. 1990;71:900
  7. Couch RM, Muller J, Winter JS. Regulation of the activities of 17-hydroxylase and 17,20-desmolase in the human adrenal cortex: kinetic analysis and inhibition by endogenous steroids. J Clin Endocrinol Metab. 1986;63(3):613–618
  8. Mortola JF, Yen SS. The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. J Clin Endocrinol Metab. 1990;71:696–704
  9. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab. 1994;78:1360
  10. Janowsky JS. The role of androgens in cognition and brain aging in men. Neuroscience. 2006;138(3):1015–1020[Epub 2005 Nov 28. Review]
  11. MacLusky NJ, Hajszan T, Prange-Kiel J, Leranth C. Androgen modulation of hippocampal synaptic plasticity. Neuroscience. 2006;138(3):957–965[Epub 2006 Feb 20. Review]
  12. Patchev VK, Schroeder J, Goetz F, Rohde W, Patchev AV. Neurotropic action of androgens: principles, mechanisms and novel targets. Exp Gerontol. 2004;39(11/12):1651–1660
  13. Martini L, Melcangi RC, Maggi R. Androgen and progesterone metabolism in the central and peripheral nervous system. J Steroid Biochem Mol Biol. 1993;47:195–205Review
  14. Pak TR, Chung WC, Lund TD, Hinds LR, Clay CM, Handa RJ. The androgen metabolite, 5alpha-androstane-3beta, 17beta-diol, is a potent modulator of estrogen receptor-beta1-mediated gene transcription in neuronal cells. Endocrinology. 2005;146:147–155[Epub 2004 Oct 7]
  15. Frye CA, Van Keuren KR, Erskine MS. Related Articles, behavioral effects of 3 alpha-androstanediol. I: modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav Brain Res. 1996;79:109–118
  16. Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev. 2003;24:152–182[Review]
  17. Sullivan SD, Moenter SM. Neurosteroids alter gamma-aminobutyric acid postsynaptic currents in gonadotropin-releasing hormone neurons: a possible mechanism for direct steroidal control. Endocrinology. 2003;144:4366–4375[Epub 2003 Jul 17]
  18. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog Neurobiol. 1992;38:379–395[Review]
  19. Corpechot C, Young J, Calvel M, et al. Neurosteroids: 3 alpha-hydroxy-5 alpha-pregnan-20-one and its precursors in the brain, plasma, and steroidogenic glands of male and female rats. Endocrinology. 1993;133:1003–1009
  20. Majewska MD, Demirgoren S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor.. Brain Res. 1990;526(1):143–146
  21. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical significance. Trends Endocrinol Metab. 2002;13:35–43[Review]
  22. Bernardi F, Casarosa E, Pluchino N, et al. Effect of dehydroepiandrosterone on central and peripheral levels of allopregnanolone and beta-endorphin. Fertil Steril. 2005;83(Suppl. 1):1161–1168
  23. Vallee M, Mayo W, Le Moal M. Role of pregnenolone, dehydroepiandrosterone and their sulfate esters on learning and memory in cognitive aging.. Brain Res Brain Res Rev. 2001;37(1–3):301–312
  24. Edinger KL, Frye CA. Testosterone's analgesic, anxiolytic, and cognitive-enhancing effects may be due in part to actions of its 5alpha-reduced metabolites in the hippocampus. Behav Neurosci. 2004;118:1352–1364
  25. Wolf OT, Neumenn O, Helhammer DH, et al. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men. J Clin Endocrinol Metab. 1997;82:2363–2367
  26. Wolkowitz OM, Reus VI, Roberts E, et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 1997;41:311–318
  27. Genazzani AR, Pluchino N, Begliuomini S, et al. Long-term low-dose oral administration of dehydroepiandrosterone modulates adrenal response to adrenocorticotropic hormone in early and late postmenopausal women. Gynecol Endocrinol. 2006;22:627–635

PII: S0378-5122(07)00067-9

doi: 10.1016/j.maturitas.2007.02.006

Maturitas
Volume 57, Issue 1 , Pages 27-30 , 20 May 2007

Article Tools